Patents by Inventor Federico Sandoval Morales

Federico Sandoval Morales has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF A CEA CD3 BISPECIFIC ANTIBODY AND A PD-1 AXIS BINDING ANTAGONIST IN A DOSAGE REGIMEN TO TREAT CANCER
    Publication number: 20200407450
    Abstract: The present invention relates to the treatment of cancer, in particular to the treatment of cancer using a CEA CD3 bispecific antibody and a PD-1 axis binding antagonist.
    Type: Application
    Filed: June 10, 2020
    Publication date: December 31, 2020
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Said BOUSEIDA, Federico SANDOVAL MORALES, Jose Maria SARO SUAREZ
  • TREATMENT METHOD
    Publication number: 20200199230
    Abstract: The present invention relates to the treatment of cancer, in particular to the prevention of adverse effects caused by the administration of CD3 antibodies in the course of said treatment.
    Type: Application
    Filed: November 22, 2019
    Publication date: June 25, 2020
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jose Saro, Said Bouseida, Federico Sandoval Morales